AU2634100A - Dmsa promoters and derivatives thereof used for controlled expression of foreigngenes - Google Patents

Dmsa promoters and derivatives thereof used for controlled expression of foreigngenes

Info

Publication number
AU2634100A
AU2634100A AU26341/00A AU2634100A AU2634100A AU 2634100 A AU2634100 A AU 2634100A AU 26341/00 A AU26341/00 A AU 26341/00A AU 2634100 A AU2634100 A AU 2634100A AU 2634100 A AU2634100 A AU 2634100A
Authority
AU
Australia
Prior art keywords
foreigngenes
dmsa
promoters
derivatives
controlled expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26341/00A
Inventor
Nadav Orr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland Baltimore
Original Assignee
University of Maryland Baltimore
University of Maryland College Park
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland Baltimore, University of Maryland College Park filed Critical University of Maryland Baltimore
Publication of AU2634100A publication Critical patent/AU2634100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU26341/00A 1999-01-27 2000-01-27 Dmsa promoters and derivatives thereof used for controlled expression of foreigngenes Abandoned AU2634100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11747099P 1999-01-27 1999-01-27
US60117470 1999-01-27
PCT/US2000/002153 WO2000044405A1 (en) 1999-01-27 2000-01-27 Dmsa promoters and derivatives thereof used for controlled expression of foreign genes

Publications (1)

Publication Number Publication Date
AU2634100A true AU2634100A (en) 2000-08-18

Family

ID=22373121

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26341/00A Abandoned AU2634100A (en) 1999-01-27 2000-01-27 Dmsa promoters and derivatives thereof used for controlled expression of foreigngenes

Country Status (2)

Country Link
AU (1) AU2634100A (en)
WO (1) WO2000044405A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002213681A1 (en) * 2000-11-09 2002-05-21 The University Of Queensland Bacterial expression systems
US11367914B2 (en) 2020-11-06 2022-06-21 ZAF Energy Systems, Incorporated Pouched metal-air battery cells
CN115785234A (en) * 2022-10-28 2023-03-14 和度生物技术(上海)有限公司 FNR mutant and application thereof in gene expression regulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783196A (en) * 1996-04-09 1998-07-21 University Of Maryland At Baltimore Gua mutants of shigella spp. and vaccines containing the same

Also Published As

Publication number Publication date
WO2000044405A1 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
AU5013100A (en) Maize rs81 promoter and methods of use thereof
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2212600A (en) Antisense modulation of g-alpha-i1 expression
AU6157396A (en) Bis-arylsulfonylaminobenzamide derivatives and the use there of as factor xa inhibitors
AU5309400A (en) Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives
AUPQ246799A0 (en) Surgical screw and guidewire
AU6111000A (en) Inhibitors of viral helcase
AU3039995A (en) Heterocyclic derivatives of N-phenylamides
AU4717301A (en) Catheter assembly and method of use
AU4357296A (en) Benzene-fused heterocyclic derivatives and use of the same
AU2177001A (en) Use of indirubine derivatives for making medicines
AU3622600A (en) Metalloproteinases and methods of use therefor
AU5668499A (en) Veneer tape and method of use
AU9016898A (en) Methods and compositions for treatment of restenosis
AU2058701A (en) Esters of vitamin D3 and uses thereof
AU6566098A (en) Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis
AU4364400A (en) Azaindole derivatives for the treatment of depression
AU6115400A (en) Antisense modulation of mekk5 expression
IL114439A0 (en) Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
AU3075595A (en) Anti-helicobacter heterocyclic derivatives of azolones
AU6019399A (en) Method of and device for machining flat parts
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU1723001A (en) Methods and means for regulation of gene expression
AU6130199A (en) Method and device for magnetic-abrasive machining of parts
AU2209000A (en) Antisense modulation of pepck-mitochondrial expression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase